The value of the dehydroepiandrosterone-annexed vitamin C infusion treatment in the clinical control of chronic fatigue syndrome (CFS). I. A Pilot study of the new vitamin C infusion treatment with a volunteer CFS patient. — CFSMEATLAS
The value of the dehydroepiandrosterone-annexed vitamin C infusion treatment in the clinical control of chronic fatigue syndrome (CFS). I. A Pilot study of the new vitamin C infusion treatment with a volunteer CFS patient.
Kodama, M, Kodama, T, Murakami, M · In vivo (Athens, Greece) · 1996
Quick Summary
This pilot study tested whether high-dose vitamin C infusions, combined with a hormone called DHEA, could help one male ME/CFS patient who also had pneumonia-like symptoms. The patient received different types of infusions over 10 months, and his pneumonia-related symptoms improved when the new DHEA-enhanced vitamin C treatment was used alongside antibiotics. The researchers measured increased levels of certain hormones in his urine after treatment.
Why It Matters
This early exploratory study investigates whether hormonal augmentation of vitamin C therapy might address both immune dysfunction and secondary infections in ME/CFS, a question relevant to understanding potential neuroendocrine contributions to disease. The proposal that endogenous steroid axis enhancement could improve ME/CFS outcomes has theoretical appeal for patients seeking mechanistic understanding of their condition.
Observed Findings
Pneumonia signs (leucocytosis, tachycardia) initially improved with standard vitamin C infusions and short-term antibiotics but recurred with prolonged treatment
Substantial extinction of pneumonia signs occurred when DHEA-annexed infusions were alternated with standard infusions and long-term antibiotics were used
Urinary 17-ketosteroids and 17-hydroxycorticosteroids increased markedly after DHEA-annexed vitamin C infusion treatment
Lymphocyte subset and NK cell percent analysis showed no coherent changes throughout the study period
DHEA appeared to be converted to testosterone based on urinary steroid metabolite patterns
Inferred Conclusions
DHEA-annexed vitamin C infusions may help control ME/CFS-related pneumonia by enhancing endogenous cortisol and testosterone activity
Pulmonary infection and CFS may share a focal infection mechanism, suggesting infectious triggers warrant investigation
The combined endocrine effect of fortified glucocorticoid and androgen activity, rather than immune modulation alone, may be therapeutically relevant in ME/CFS
Remaining Questions
Why did standard lymphocyte and NK cell measurements fail to detect immune changes if the treatment mechanism is immunological?
What This Study Does Not Prove
This is a single-case report without concurrent controls, blinding, or randomization, so it cannot establish causation or prove that the DHEA-vitamin C combination caused the observed improvements rather than natural disease fluctuation or antibiotic therapy alone. The study does not demonstrate that this treatment is effective for ME/CFS patients more broadly, nor does it rule out placebo effects or spontaneous remission. The inability to detect lymphocyte changes undermines the proposed immune mechanism.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →